| | |
Sumeet Chatterjee and Ben Hirschler / Reuters 03:09 PM | September 18,2009
Deal would be win-win for both drugmakers, say analysts
|
|
Lison Joseph 06:52 PM | January 20,2009
Palepu was an independent director on the board of Satyam
|
|
PTI 04:21 PM | October 23,2008
The company’s total income rose to Rs955.1 crore for the quarter under review, from Rs924.4 crore for the same period a year ago
|
|
Lison Joseph 12:19 AM | October 17,2008
Dr Reddy’s was the first Indian drug company to hive off its drug discovery related research and development activities into a separate firm
|
|
Bhuma Shrivastava 12:50 AM | July 14,2008
The Indian rupee depreciated by 6.9% against the US dollar during the quarter, compared to 1% depreciation in the previous two quarters
|
|
Lison Joseph 11:56 PM | April 23,2008
Facilities there can help Indian firms tap the local market, Europe, Africa and West Asia
|
|
Devidutta Tripathy / Reuters 12:30 AM | April 18,2008
Ranbaxy Laboratories Ltd, India’s top drug maker by sales, is expected to post a 15.5% rise in March quarter sales
|
|
C.H. Unnikrishnan 12:05 AM | February 13,2008
Divided opinion among govt agencies may put paid to any hopes of being treated on a par with in-house R&D
|
|
C.H. Unnikrishnan 09:58 PM | November 18,2007
With annual sales of $58 billion, Japan is the second largest pharmaceutical market after the US
|
|
Rajeshwari Sharma 12:28 AM | November 12,2007
More firms in India are moving from traditional rewards systems to ‘total rewards’—but effectiveness still depends on the selection of performers
|
|